[go: up one dir, main page]

DE69632625D1 - Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose - Google Patents

Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose

Info

Publication number
DE69632625D1
DE69632625D1 DE69632625T DE69632625T DE69632625D1 DE 69632625 D1 DE69632625 D1 DE 69632625D1 DE 69632625 T DE69632625 T DE 69632625T DE 69632625 T DE69632625 T DE 69632625T DE 69632625 D1 DE69632625 D1 DE 69632625D1
Authority
DE
Germany
Prior art keywords
proteins
zuberkulose
mycrobacterial
vaccine
organisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69632625T
Other languages
English (en)
Other versions
DE69632625T2 (de
Inventor
Anne Laqueyrerie
Gilles Marchal
Pascale Pescher
Felix Romain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Application granted granted Critical
Publication of DE69632625D1 publication Critical patent/DE69632625D1/de
Publication of DE69632625T2 publication Critical patent/DE69632625T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69632625T 1995-02-01 1996-01-31 Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose Expired - Lifetime DE69632625T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/382,184 US5714593A (en) 1995-02-01 1995-02-01 DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
US382184 1995-02-02
PCT/FR1996/000166 WO1996023885A1 (fr) 1995-02-01 1996-01-31 Proteines de mycobacteries, microorganismes les produisant et leurs utilisations vaccinales et pour la detection de la tuberculose

Publications (2)

Publication Number Publication Date
DE69632625D1 true DE69632625D1 (de) 2004-07-08
DE69632625T2 DE69632625T2 (de) 2005-06-09

Family

ID=23507871

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69632625T Expired - Lifetime DE69632625T2 (de) 1995-02-01 1996-01-31 Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose

Country Status (12)

Country Link
US (7) US5714593A (de)
EP (1) EP0807178B1 (de)
JP (3) JPH10513349A (de)
AT (1) ATE268385T1 (de)
AU (1) AU700514B2 (de)
CA (1) CA2210928A1 (de)
DE (1) DE69632625T2 (de)
DK (1) DK0807178T3 (de)
ES (1) ES2217303T3 (de)
NZ (1) NZ301290A (de)
PT (1) PT807178E (de)
WO (1) WO1996023885A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714593A (en) 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
JP2001500383A (ja) * 1996-10-11 2001-01-16 コリックサ コーポレーション 結核診断用の化合物および方法
FR2758144B1 (fr) * 1997-01-08 1999-04-02 Pasteur Institut Polynucleotide codant pour un polypeptide de 27 kd de mycobacteries appartenant au complexe de mycobacterium tuberculosis, application au diagnostic et a la prevention de la tuberculose
FR2766495B1 (fr) * 1997-07-22 2001-07-13 Pasteur Institut Souche de mycobacterium dont le gene erp est modifie et composition vaccinale la contenant
FR2767337B1 (fr) 1997-08-14 2002-07-05 Pasteur Institut Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
WO2001024820A1 (en) * 1999-10-07 2001-04-12 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US6316205B1 (en) * 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
WO2001062893A2 (en) * 2000-02-25 2001-08-30 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
SI1542732T1 (sl) * 2000-06-20 2010-01-29 Corixa Corp Csc The United Sta Fuzijski proteini Mycobacterium tuberculosis
AU2001271963A1 (en) * 2000-07-10 2002-01-21 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
FR2818647B1 (fr) * 2000-12-21 2006-09-29 Pasteur Institut Glycopeptides immunogenes, criblage, preparation et applications
WO2003063798A2 (en) * 2002-02-01 2003-08-07 Cornell Research Foundation, Inc. Compositions and methods for treatment of infectious and inflammatory diseases
US20050267025A1 (en) * 2002-02-01 2005-12-01 Ho John L Compositions and methods for treatment of infectious and inflammatory diseases
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
ATE360097T1 (de) * 2002-02-25 2007-05-15 Pasteur Institut Spezifisch vom genom von mycobacterium tuberculosis deletierte sequenzen und deren verwendung in der diagnostik und als vakzine
CN100393876C (zh) * 2004-05-11 2008-06-11 中国人民解放军第三○九医院 用于结核病诊断的结核分枝杆菌蛋白
TWI285861B (en) * 2004-05-21 2007-08-21 Sanyo Electric Co Display device
US7820142B2 (en) 2004-09-30 2010-10-26 Institut Pasteur Immunogenic glycopeptides, screening, preparation and uses
US8475735B2 (en) * 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
US8303827B2 (en) * 2008-11-13 2012-11-06 Pixart Imaging Incorporation Method for making micro-electro-mechanical system device
EP2573107A1 (de) * 2011-09-21 2013-03-27 Norwegian Institute of Public Health Rekombinantes Fusionsprotein
US10450349B2 (en) 2016-03-04 2019-10-22 Purdue Research Foundation Multivalent fibronectin-integrin binding compositions and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
FR2688785B1 (fr) * 1992-03-19 1995-07-07 Pasteur Institut Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein

Also Published As

Publication number Publication date
AU4667596A (en) 1996-08-21
US20040142453A1 (en) 2004-07-22
NZ301290A (en) 1998-12-23
US7101555B2 (en) 2006-09-05
JP4276670B2 (ja) 2009-06-10
JP2007044045A (ja) 2007-02-22
PT807178E (pt) 2004-10-29
WO1996023885A1 (fr) 1996-08-08
JPH10513349A (ja) 1998-12-22
US6221353B1 (en) 2001-04-24
JP2008212160A (ja) 2008-09-18
EP0807178B1 (de) 2004-06-02
DE69632625T2 (de) 2005-06-09
ES2217303T3 (es) 2004-11-01
AU700514B2 (en) 1999-01-07
US5714593A (en) 1998-02-03
US6676945B2 (en) 2004-01-13
US6335181B1 (en) 2002-01-01
US5866130A (en) 1999-02-02
EP0807178A1 (de) 1997-11-19
ATE268385T1 (de) 2004-06-15
DK0807178T3 (da) 2004-10-11
CA2210928A1 (fr) 1996-08-08
US6379902B1 (en) 2002-04-30
US20030054008A1 (en) 2003-03-20
JP4283872B2 (ja) 2009-06-24

Similar Documents

Publication Publication Date Title
DE69632625D1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
TR199902124T2 (xx) �ltihapl� hastal�klar�n tedavisinde yararl� k���k molek�ller.
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
NZ316787A (en) Methods and compositions for the selective modification of nucleic acids
ATE257390T1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
AU2236795A (en) Afamin: a human serum albumin-like protein
DE69536113D1 (de) Rezeptor für modifizierte Lipoprotein niedriges Molekulargewichtes
ATE183241T1 (de) Impstoff gegen streptococcus suis-infektion
DK0821693T3 (da) Nye DNA-sekvenser fra human cytomegalovirus (HCMV)
CY1108288T1 (el) Αντισωματα για το αντιγονο κυτταρων langerhans θηλαστικων και χρησεις τους
ATE214399T1 (de) Mycobacteriumprotein und dessen verwendung
CA2185112A1 (en) Humanized monoclonal antibodies against human interleukin-4
DE69714451D1 (de) Prionbindende proteine und deren verwendungen
DK0914043T3 (da) Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf
DE69522564D1 (de) Alkalibeständiges proteinadsorbens
DE69524971D1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
IT1317849B1 (it) Mezzi e metodi per l'espressione di proteine omologhe ed eterologhe inceppi di rhodococcus.
WO1992011367A3 (en) Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
ATE355301T1 (de) Moraxella catharralis proteine
BR9407357A (pt) Novos tripeptideos utilizáveis em terapia cns e imune
DE69421665D1 (de) Anomere Fluorribosylamine
AU9350298A (en) Novel gene defective in apeced and its use
DE50211352D1 (de) Vektorsystem zum screening von wirkstoffen
BR1100889A (pt) Proteìna hìbrida, sequência de dna, vetor, hospedeiro, partìcula de lipoproteìna multimérica, vacina, uso da vacina e processos de produção de proteìnas hìbridas e partìculas
MX9703191A (es) Anticuerpos contra proteinas alogenicas y xenogenicas, su uso en diagnostico y terapia y metodos para la determinacion de los mismos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition